N

Nanoform Finland Oyj
F:4YL

Watchlist Manager
Nanoform Finland Oyj
F:4YL
Watchlist
Price: 1.152 EUR -1.87% Market Closed
Market Cap: 98.5m EUR

Net Margin
Nanoform Finland Oyj

-736.7%
Current
-766%
Average
1.1%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-736.7%
=
Net Income
-21.8m
/
Revenue
3m

Net Margin Across Competitors

No Stocks Found

Nanoform Finland Oyj
Glance View

Nanoform Finland Oyj engages in providing expert services in nanotechnology and drug particle engineering for the international pharma industry. The company is headquartered in Helsinki, Etela-Suomen and currently employs 158 full-time employees. The company went IPO on 2020-06-04. The firm is an early-stage growth Company that develops various nanoforming technologies for application in the field of nanomedicine. Nanoform Finland Oyj’s business is to offer expert services in nanotechnology as well as drug particle engineering for global pharma and biotech industry. Nanoform Finland Oyj is the Parent Company of the Nanoform Group, and it has one subsidiary - Nanoform USA Inc. The Group production, research and development functions operate in Finland. The Group’s strategy is to sell nanotechnological services widely to minimize the dependence from single customers or projects.

4YL Intrinsic Value
HIDDEN
Show
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-736.7%
=
Net Income
-21.8m
/
Revenue
3m
What is the Net Margin of Nanoform Finland Oyj?

Based on Nanoform Finland Oyj's most recent financial statements, the company has Net Margin of -736.7%.

Back to Top